Discordance between PSA level and PCa includes cases where patients with metastatic disease have undetectable PSA levels [3], patients with elevated PSA levels post-treatment who never develop metastatic disease [4], and patients for whom PSA values either do not directly correlate with, or are inversely correlated with, disease progression [4]. This evidence concerns the gene KLK3 and metastatic neoplasm.